Vascular compliance in the cardiometabolic syndrome
1Division of Endocrinology, Diabetes, and Hypertension, State University of New York Heath Science Center, Brooklyn, NY 11203, USA.
Insights
Elevated blood pressure predicts vascular stiffening and related diseases. New noninvasive methods help understand arterial stiffness, enabling early interventions for better vascular health.
Area of Science:
- Cardiovascular Science
- Biomedical Engineering
- Metabolic Disease Research
Background:
- Elevated systolic blood pressure and pulse pressure are key indicators of vascular stiffening.
- Vascular stiffening is linked to serious conditions like heart disease, stroke, and kidney disease.
- Arterial stiffness contributes to cardiometabolic syndrome through insulin resistance, endothelial dysfunction, inflammation, and sympathetic activation.
Purpose of the Study:
- To review noninvasive methods for measuring arterial stiffness and vascular compliance.
- To explore pathological processes contributing to increased arterial stiffness in cardiometabolic syndrome.
- To discuss strategies for improving vascular compliance.
Main Methods:
- Review of noninvasive techniques for assessing arterial stiffness.
- Analysis of pathological mechanisms driving vascular dysfunction.
- Discussion of therapeutic and lifestyle interventions.
Main Results:
- Noninvasive methods have advanced the understanding of vascular dysfunction mechanisms.
- Arterial stiffness is associated with multiple comorbidities in cardiometabolic syndrome.
- Early detection and monitoring of arterial stiffness can guide interventions.
Conclusions:
- Accurate measurement of vascular compliance is crucial for disease prediction and management.
- Addressing underlying pathologies like insulin resistance and inflammation can improve vascular health.
- Improving vascular compliance offers a potential strategy to prevent or slow disease progression.
Abstract:
Elevated systolic blood pressure and increased pulse pressure are important predictors of vascular stiffening (compliance), left ventricular hypertrophy, coronary heart disease, heart failure, stroke, vascular dementia, and chronic kidney disease. Advances in noninvasive methods that measure arterial stiffness have led to increased understanding of the mechanisms underlying vascular dysfunction and the development of associated risk factors. The ability to detect and monitor changes in the physical properties of arteries has the potential to allow early interventions that may prevent disease or attenuate its progression. In this paper, the authors briefly review the various methods available to measure vascular compliance and review pathologic processes that lead to insulin resistance, endothelial dysfunction, inflammation, and sympathetic activation, all of which may contribute to increased arterial stiffness in the cardiometabolic syndrome. Strategies to improve vascular compliance are also discussed.
Related Concept Videos
Vascular Resistance
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Coronary Artery Disease I: Introduction
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Assessment of the Cardiovascular System II: Inspection
Head and Neck
Cardiomyopathy III: Hypertrophic Cardiomyopathy

